LifeArc, a self-funded, non-profit medical research organisation is seeking innovative proposals to boost drug repurposing in MND by investing at least £5m in preclinical translation. The funding call is part of LifeArc’s multi-million pound MND Translational Challenge to help accelerate scientific innovation and find new treatments for people living with MND.
LifeArc will provide funding and support for researchers and SMEs who possess a repurposed...
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.